Cancer drug attacking cancer cells. 3D computer illustration of the monoclonal antibody drug cetuximab (orange) attacking cancer cells (round). Cetuximab is a chemotherapy drug, used to treat metastatic colon cancer. It acts by inhibiting epidermal growth factor receptor (EGFR), therefore blocking the signals that tell the cancer cells to grow and divide.
Delhi’s Lok Nayak Jai Prakash Narayan Hospital (LNJP) ahad begun Monoclonal Antibody Cocktail used to treat mild to moderate “high risk” patients who are Covid positive, free of cost.
“We have received a Monoclonal Antibody Cocktail– a combination of Casirivimab and Imdevimab. We have started using it in LNJP hospital. Now we will be able to provide the latest medicines for the Covid-19 patients. These are the monoclonal antibodies and they are very useful,” said Dr Suresh Kumar, Managing Director, LNJP hospital”We will have first-time experience of these drug cocktails or antibody cocktails.
Earlier patients were going to the private hospitals to get this treatment, but now the government has made a provision and we are giving it in LNJP. We are giving it free of cost.”Roche India and Cipla had announced the launch of the Antibody Cocktail in India last week.
Priced at ₹59,750 for a dose, the therapy has been earlier introduced in private hospitals Fortis Escorts, Moolchand, Apollo, Sir Gangaram, and Max Hospital.
In recent years, diet and lifestyle have been recognized as crucial factors influencing cancer risk.…
Surgical advancements have evolved significantly over the decades, leading to improved precision, reduced recovery time,…
A tragic incident in northwest Delhi has sparked a medical negligence controversy after a 20-year-old…
Maharashtra is set to witness a significant transformation in its public health sector with the…
Sleep is essential for overall health, yet many people suffer from sleep disorders that disrupt…
Sleep is often regarded as a luxury in today’s fast-paced world, but scientific research continuously…